ArticleMedicine2024

Low-dose apatinib in combination with chemotherapy for hormone receptor-positive, HER2-negative breast cancer with pulmonary lymphangitic carcinomatosis: A case report.

Liping Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.